Claudia Seifarth1, Lara Börner2, Britta Siegmund3, Heinz Johannes Buhr2, Jörg-Peter Ritz4, Jörn Gröne2. 1. Department of Surgery, Charité - Universitätsmedizin Berlin, Campus Benjamin Franklin, Hindenburgdamm 30, 12200, Berlin, Germany. claudia.seifarth@charite.de. 2. Department of Surgery, Charité - Universitätsmedizin Berlin, Campus Benjamin Franklin, Hindenburgdamm 30, 12200, Berlin, Germany. 3. Department of Medicine, Charité - Universitätsmedizin Berlin, Campus Benjamin Franklin, Berlin, Germany. 4. Department of Surgery, HELIOS Kliniken, Schwerin, Germany.
Abstract
INTRODUCTION: Coloproctomucosectomy (CPM) with ileopouchanal anastomosis (IPAA), as the procedure of choice for surgical management of ulcerative colitis (UC), is commonly performed either as a 2- or 3-staged procedure. For patients with considerable immunosuppression, reduced nutritional or general health status, and as part of emergency treatment, a 3-staged (3S) procedure is recommended by guidelines to minimize perioperative complication rates compared to 2-staged (2S) procedure. However, the necessity of additional hospitalization and surgery is suspect to affect quality of life (QoL). In this prospective, observational study, we evaluate the long-term QoL after 2- and 3-staged interventions of CPM with IPAA for patients with UC. PATIENTS AND METHODS: Between 1997 and 2011, a total of 233 patients underwent CPM and had a 2- or 3-staged procedure. In 108 patients, surgical procedure was completed, and evaluation of QoL was performed by specific questionnaires (IBDQ, FIQoL, SF-12, CCS) up to 20 years after ileostomy closure. Data were collected within the framework of a prospective study. RESULTS: Observing a total of 84 patients (2S: n = 59; 3S: n = 25), QoL measured by IBDQ was higher after CPM, compared to preoperative (2S: 15 → 31; 3S: 17 → 28; p < 0.01), with no differences between 2S or 3S procedures (p > 0.05). Specific QoL assessment concerning incontinence and stool frequency (CCS, FIQoL) did not differ either (CCS: 2S:3S = 12:15; p > 0.05). General health-related QoL, determined by SF-12 score, did not differ between 2S or 3S procedures. CONCLUSION: The indication for a 2-staged or 3-staged procedure should be adjusted to the severity of the underlying disease, nutritional status of the patient, and the extent of immunosuppression at the time of surgery. It should not be affected by the fear of complications or a reduced quality of life by additional surgery in 3-staged versus 2-staged procedures.
INTRODUCTION: Coloproctomucosectomy (CPM) with ileopouchanal anastomosis (IPAA), as the procedure of choice for surgical management of ulcerative colitis (UC), is commonly performed either as a 2- or 3-staged procedure. For patients with considerable immunosuppression, reduced nutritional or general health status, and as part of emergency treatment, a 3-staged (3S) procedure is recommended by guidelines to minimize perioperative complication rates compared to 2-staged (2S) procedure. However, the necessity of additional hospitalization and surgery is suspect to affect quality of life (QoL). In this prospective, observational study, we evaluate the long-term QoL after 2- and 3-staged interventions of CPM with IPAA for patients with UC. PATIENTS AND METHODS: Between 1997 and 2011, a total of 233 patients underwent CPM and had a 2- or 3-staged procedure. In 108 patients, surgical procedure was completed, and evaluation of QoL was performed by specific questionnaires (IBDQ, FIQoL, SF-12, CCS) up to 20 years after ileostomy closure. Data were collected within the framework of a prospective study. RESULTS: Observing a total of 84 patients (2S: n = 59; 3S: n = 25), QoL measured by IBDQ was higher after CPM, compared to preoperative (2S: 15 → 31; 3S: 17 → 28; p < 0.01), with no differences between 2S or 3S procedures (p > 0.05). Specific QoL assessment concerning incontinence and stool frequency (CCS, FIQoL) did not differ either (CCS: 2S:3S = 12:15; p > 0.05). General health-related QoL, determined by SF-12 score, did not differ between 2S or 3S procedures. CONCLUSION: The indication for a 2-staged or 3-staged procedure should be adjusted to the severity of the underlying disease, nutritional status of the patient, and the extent of immunosuppression at the time of surgery. It should not be affected by the fear of complications or a reduced quality of life by additional surgery in 3-staged versus 2-staged procedures.
Entities:
Keywords:
Multistep proctocolectomy; Quality of life; Surgery; Ulcerative colitis
Authors: J T Heikens; J de Vries; M R E Goos; H J Oostvogel; H G Gooszen; C J H M van Laarhoven Journal: Br J Surg Date: 2011-11-03 Impact factor: 6.939
Authors: Victor Warren Fazio; Ravi P Kiran; Feza H Remzi; John Calvin Coffey; Helen Mary Heneghan; Hasan Tarik Kirat; Elena Manilich; Bo Shen; Sean T Martin Journal: Ann Surg Date: 2013-04 Impact factor: 12.969
Authors: Danielle D Antosh; Cara L Grimes; Aimee L Smith; Sarah Friedman; Brook L McFadden; Catrina C Crisp; Arielle M Allen; Robert E Gutman; Rebecca G Rogers Journal: Int J Gynaecol Obstet Date: 2013-05-22 Impact factor: 3.561
Authors: F López-Rosales; Q González-Contreras; L J Muro; M M Berber; H T Cid de León; O V Fernández; R R Veana Journal: Surg Endosc Date: 2007-08-20 Impact factor: 4.584
Authors: Marc Ferrante; Sarah Declerck; Gert De Hertogh; Gert Van Assche; Karel Geboes; Paul Rutgeerts; Freddy Penninckx; Séverine Vermeire; Andre D'Hoore Journal: Inflamm Bowel Dis Date: 2008-01 Impact factor: 5.325
Authors: Olga A Lavryk; Luca Stocchi; Tracy L Hull; Emre Gorgun; Sherief Shawki; Jeremy M Lipman; Stefan D Holubar; Conor P Delaney; Scott R Steele Journal: J Gastrointest Surg Date: 2018-08-10 Impact factor: 3.452
Authors: Boris Jansen-Winkeln; Jonathan P Takoh; Claire Chalopin; Marianne Maktabi; Orestis Lyros; Robert Sucher; Albrecht Hoffmeister; Niels Teich; Hannes Köhler; Ines Gockel Journal: Visc Med Date: 2021-04-13
Authors: Jan P Frese; Jörn Gröne; Johannes C Lauscher; Martin E Kreis; Benjamin Weixler; Katharina Beyer; Claudia Seifarth Journal: Int J Colorectal Dis Date: 2022-06-17 Impact factor: 2.796
Authors: Jörn Gröne; Eva-Maria Lorenz; Claudia Seifarth; Hendrik Seeliger; Martin E Kreis; Mario H Mueller Journal: Int J Colorectal Dis Date: 2018-07-12 Impact factor: 2.571
Authors: Bharati Kochar; Edward L Barnes; Anne F Peery; Katherine S Cools; Joseph Galanko; Mark Koruda; Hans H Herfarth Journal: Inflamm Bowel Dis Date: 2018-07-12 Impact factor: 5.325